- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02571790
Virtual Reality and Relaxation for the Treatment of Generalized Anxiety Disorders: a Comparative Study With Standard Relaxation (Relax-TAG)
The purpose is threefold: Assess the anxiety reduction, the mood positive effect and the rise of quality of life when using methods of relaxation combined with virtual reality with patients suffering from generalized anxiety disorder in comparison of the effect of traditional relaxation therapy. Observe and evaluate the effect of perceived presence in synthetic environments in the virtual experience of relaxation. Evaluate the therapeutic efficacy of stereoscopy during exposure to relaxing virtual environments for the treatment of generalized anxiety disorder.
It is a comparative, randomized, two groups study (29 in each group):
- Relaxation optimized virtual reality
- Classical relaxation (without Virtual Reality). The protocol comprised for each groups 7 relaxing sessions (with or without virtual reality epending on the group). Each session lasted for approximately 30 to 35 minutes, including a 5-minute pause between immersive trials, in order to avoid cyber sickness in the virtual reality group.
Expected results: a measurable therapeutic improvement produced by the combination of relaxation and virtual and its additional effect when compared to the traditional treatment.
Measurements of variables and therapeutic effects will be carried out with psychometric measures.
The creation process of the relaxing virtual environments has already been completed. The virtual environments are ready for use.
The apparatus needed and in our possession include:
- A laptop for generating virtual environments
- A stereoscopic display
- Apparatus for physiological measurements
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or Female.
- Age 18-65 years inclusive.
- Generalized Anxiety Disorders primary diagnosis in patients according with major depressive episode V (DSM-V) criteria.
- Topic speaking English or French language
- Subject who have signed a written informed consent and undertaking to comply with the instructions of the protocol.
Exclusion Criteria:
- Subject not having at least one inclusion criterion;
- Minor Subject, pregnant or nursing women, about not being affiliated to the social security scheme, or deprived of liberty subject;
- Age greater than 18 and less than 65 years.
- Subject Trust;
- Subject indication against having a virtual reality: epilepsy, major organ failure, severe myopia, acute psychiatric disorder (such as schizophrenia in acute period, paranoia, manic, or melancholic major depression).
- Subject did not sign the informed consent, or topic for which the legal representative has not signed this consent in cases where the subject is under curatorship.
- Subject wishing to interrupt his participation in the study before the end;
- Subject for which the occurrence of an event makes it necessary to interrupt the therapy program before the end
- History of neurological disease, head injury or mental retardation.
- Presence of a psychotic disorder decompensated
- Presence of addictologique comorbidity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Relaxation optimized virtual reality
six relaxation sessions with virtual reality
|
|
Experimental: Classical relaxation (without Virtual Reality).
six relaxation sessions without virtual reality
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
scores on psychometric scales in connection with the Generalized Anxiety Disorders (TAG)
Time Frame: 24 months
|
Penn State Worry Questionnaire
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Short self-completion questionnaire on the Generalized Anxiety Disorders (TAG)
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-23
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorders
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Chinese University of Hong KongCompleted
-
Coordinación de Investigación en Salud, MexicoUnknownGeneralized Anxiety DisorderMexico
-
Ryerson UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Mind Medicine, Inc.CompletedAnxiety GeneralizedUnited States
-
The Hong Kong Polytechnic UniversityCompletedAnxiety GeneralizedHong Kong
-
Carmen AndreescuCompletedAnxiety Disorders GeneralizedUnited States
-
Xijing HospitalRecruitingGeneralized Anxiety DisorderChina
-
Sichuan Jishengtang Pharmaceutical Co., Ltd.Not yet recruitingGeneralized Anxiety Disorder
-
Hospital de Clinicas de Porto AlegreRecruitingGeneralized Anxiety DisorderBrazil
Clinical Trials on Relaxation optimized virtual reality
-
Istituto Auxologico ItalianoCompletedGeneralized Anxiety DisorderItaly
-
King's College LondonCompletedStress, Psychological | Psychological Burnout | Mental Health BurdenUnited Kingdom
-
University of TurkuCity of Helsinki; University of Dundee; University of St AndrewsCompleted
-
State Budgetary Healthcare Institution, National...CompletedThe Impact of Virtual Reality on the Emotional State of Patients With Aphasia During Rehabilitation.Aphasia | Virtual Reality | Emotional DisturbancesRussian Federation
-
Thomas More University of Applied SciencesUniversitair Ziekenhuis Brussel; Algemeen Ziekenhuis Sint_MaartenCompletedPain | Stress | AnxietyBelgium
-
University of Missouri-ColumbiaCompletedPain, Chronic | Insomnia ChronicUnited States
-
Spaulding Rehabilitation HospitalCompletedChronic Low Back PainUnited States
-
Rennes University HospitalEquipe Hybrid, INRIA - Campus Universitaire de Beaulieu - F-35042 Rennes...Recruiting
-
Ataturk UniversityCompletedVirtual Reality | Bronchoscopy | Relaxation Program | GlassesTurkey
-
Ataturk UniversityCompleted